Use of Ondansetron and Other Antiemetics in the Management of Toxic Acetaminophen Ingestions

References

• Tobias J D, Gregory D F, Deshpande J K. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication. Pediatr Emerg Care 1992; 8: 345–346
   PubMed Web of Science ®Google Scholar
• Reed M D, Marx C M. Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmacother 1994; 28: 331–333
   PubMed Web of Science ®Google Scholar
• Clark R F, Chen R, Williams S R, Johnson C L, Harchelroad F. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicol Clin Toxicol 1996; 34: 163–167
   PubMed Web of Science ®Google Scholar
• Marty M, Pouillart P, Scholl S, et al. Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclo-pramide in the control of cisplatin-induced emesis. N Engl J Med 1990; 322: 816–821
   PubMed Web of Science ®Google Scholar
• Hainsworth J, Harvey W, Pendergrass K, et al. A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 1991; 9: 721–728
   PubMed Web of Science ®Google Scholar
• Markham A, Sorkin E M. Ondansetronm. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993; 45: 931–952
   PubMed Web of Science ®Google Scholar
• Drug Topics Red Book, M S Rangell. Medical Economics, Montvale, NJ 1996
   Google Scholar
• Litovitz T L, Felberg L, White S, Klein-Schwartz W. 1995 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1996; 14: 487–537
   PubMed Web of Science ®Google Scholar
• Rumack B H, Peterson R C, Koch G G, Amara L A. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981; 141: 380–385
   PubMed Web of Science ®Google Scholar
• Smith T. Differences between general practices in hospital admission rates for self-inflicted injury and self-poisoning: Influence of socioeconomic factors. Br J Gen Pract 1995; 45: 458–462
   PubMed Web of Science ®Google Scholar
• Kerfoot M, Dyer E, Harrington V, Woodham A, Harrington R. Correlates and short-term course of self-poisoning in adolescents. Br J Psychiatry 1996; 168: 38–42
   PubMed Web of Science ®Google Scholar
• Gilbertson R J, Harris E, Pandey S K, Kelly P, Myers W. Paracetamol use, availability, and knowledge of toxicity among British and American adolescents. Arch Dis Child 1996; 75: 194–198
   PubMed Web of Science ®Google Scholar
• Hawton K, Ware C, Mistry H, et al. Why patients choose paracetamol for self poisoning and their knowledge of its dangers. BMJ 1995; 310: 164
   PubMed Web of Science ®Google Scholar
• Bryson J C. Clinical safety of ondansetron. Semin Oncol 1992; 19: 26–32
   PubMed Web of Science ®Google Scholar
• Finn A L. Toxicity and side effects of ondansetron. Semin Oncol 1992; 19: 53–60
   PubMed Web of Science ®Google Scholar
• Garcia-del-Muro X, Cardenal F, Ferrer P. Extrapyramidal reaction associated with ondansetron. Eur J Cancer 1993; 29A: 288
   PubMed Web of Science ®Google Scholar
• Halperin J R, Murphy B. Extrapyramidal reaction to ondansetron. Cancer 1992; 69: 1275
   PubMed Web of Science ®Google Scholar
• Dobrow R B, Coppock M A, Hosenpud J R. Extrapyramidal reaction caused by ondansetron. J Clin Oncol 1991; 9: 1921
   PubMed Web of Science ®Google Scholar
• Kossey J L, Kwok K K. Anaphylactoid reactions associated with ondansetron. Ann Pharmacother 1994; 28: 1029–1030
   PubMed Web of Science ®Google Scholar
• McEvoy G K, Litvak K, Welsh O H, et al. American Hospital Formulary Service Drug Information. American Society of Hospital Pharmacists, Inc., Bethesda, MD 1996
   Google Scholar
• Miller L F, Rumack B H. Clinical safety of high oral doses of acetylcysteine. Semin Oncol 1983; 10: 76–85
   PubMed Web of Science ®Google Scholar
• Rosencrance J G, Scharman E J. Anaphylactoid reaction to oral N-acetylcysteine: A case report. Vet Hum Toxicol 1993; 35: 357
   Google Scholar
• Sunman W, Hughes A D, Sever P S. Anaphylactoid response to intravenous acetylcysteine. Lancet 1992; 339: 1231–1232
   PubMed Web of Science ®Google Scholar
• Chan T Y, Critchley J A. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp Toxicol 1994; 13: 542–544
   PubMed Web of Science ®Google Scholar
• Bailey B, McGuigan M. Management of allergoid and anaphylactoid reactions to IV N-acetylcysteine (NAC). J Toxicol Clin Toxicol 1996; 34: 585–586
   Google Scholar
• Bonfiglio M F, Traeger S M, Hulisz D T, Martin B R. Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities. Ann Pharmacother 1992; 26: 22–25
   PubMed Web of Science ®Google Scholar
• Mant T G, Tempowski J H, Volans G N, Talbot J C. Adverse reactions to acetylcysteine and effects of overdose. Br Med J Clin Res Ed 1984; 289: 217–219
   PubMed Web of Science ®Google Scholar
• Lewis R K, Paloucek F P. Assessment and treatment of acetaminophen overdose. Clin Pharm 1991; 10: 765–774
   PubMedGoogle Scholar
• Smilkstein M J, Bronstein A C, Linden C, Augenstein W L, Kulig K W, Rumack B H. Acetaminophen overdose: A 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 10: 1058–1063
   Google Scholar
• Keays R, Harrison P M, Wendon J A, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991; 303: 1026–1029
   PubMed Web of Science ®Google Scholar
• Smilkstein M J, Knapp G L, Kulig K W, Rumack B H. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319: 1557–1562
   PubMed Web of Science ®Google Scholar
• Brown S G, Prentice D A. Ondansetron in the treatment of theophylline overdose. Med J Aust 1992; 156: 512
   PubMed Web of Science ®Google Scholar
• Sage T A, Jones W N, Clark R F. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity. Ann Pharmacother 1993; 27: 584–585
   PubMed Web of Science ®Google Scholar